Want to see HK:2197 full AI Analyst Report?
Clover Biopharmaceuticals Ltd. (2197) Income Statement
Clover Biopharmaceuticals Ltd. Income Statement
Last quarter (Q2 2026), Clover Biopharmaceuticals Ltd.'s total revenue was $176.53K, an increase of 101.75% from the same quarter last year. In Q2, Clover Biopharmaceuticals Ltd.'s net income was $941.79M. See Clover Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.41M | $ 38.42M | $ 39.26M | $ 0.00 | $ 0.00 | |
| $ -23.85M | $ -672.94M | $ 24.24M | $ -475.64M | $ -66.27M | |
| $ 223.91M | $ 278.26M | $ 896.33M | $ 1.88B | $ 2.17B | |
| Depreciation and Amortization | $ 26.52M | $ 40.32M | $ 74.74M | $ 56.62M | $ 24.49M |
| $ -221.24M | $ -914.52M | $ -45.07M | $ -2.34B | $ -2.21B | |
| $ -247.75M | $ -951.21M | $ -2.58B | $ -2.35B | $ -2.24B | |
| $ 47.97M | $ 47.78M | $ 2.44B | $ -100.70M | $ -3.78B | |
| $ -199.78M | $ -903.43M | $ -138.54M | $ -2.45B | $ -6.02B | |
| $ -199.78M | $ -903.43M | $ -138.54M | $ -2.45B | $ -6.02B | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.16 | $ -0.72 | $ -0.11 | $ -2.22 | $ -5.37 |
| Diluted EPS | $ -0.16 | $ -0.72 | $ -0.11 | $ -2.22 | $ -5.36 |
| Weighted Average Shares Outstanding | 1.26B | 1.25B | 1.24B | 1.10B | 1.12B |
| Weighted Average Shares Outstanding (Diluted) | 1.26B | 1.25B | 1.24B | 1.10B | 1.12B |
Currency in CNY
